# Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer

> **NCT06306755** · NA · RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 21000 (estimated)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer
- Precision Screening
- Sequential Screening
- Risk Stratification

## Interventions

- **PROCEDURE:** Risk Assessment and Individualized Surveillance
- **PROCEDURE:** Universal screening

## Key facts

- **NCT ID:** NCT06306755
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2028-12
- **Final completion:** 2034-12
- **Target enrollment:** 21000 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306755, "Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06306755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*